Baird analyst Eric Coldwell raised the firm’s price target on Premier (PINC) to $20 from $19 and keeps a Neutral rating on the shares. The firm said ti posted a positive print, against low valuation and poor sentiment and while health system utilization remains strong and member purchasing growing, remainder of FY25 may prove lower given GPO contract renewal process and fee share increases.